Stockscreener 앱 받기
11.95
1.96%
0.23
Celcuity Inc 주식(CELC)의 최신 뉴스
JPMorgan Chase & Co. Sells 11,612 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
When (CELC) Moves Investors should Listen - Stock Traders Daily
Jefferies lifts Celcuity stock target to $33, maintains Buy rating - MSN
Jefferies lifts Celcuity stock target to $33, maintains Buy rating By Investing.com - Investing.com Australia
Hennion & Walsh Asset Management Inc. Buys 71,006 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Holdings Raised by Barclays PLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Bought by Barclays PLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Brokerages - MarketBeat
Analyzing Celcuity (NASDAQ:CELC) and CannLabs (OTCMKTS:CANL) - Defense World
Jane Street Group LLC Sells 9,921 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity stock touches 52-week low at $11.51 amid market challenges - Investing.com Australia
Objective long/short (CELC) Report - Stock Traders Daily
Geode Capital Management LLC Acquires 136,518 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Geode Capital Management LLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Raises Stock Position in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity (NASDAQ:CELC) Trading Up 3.8%Here's Why - MarketBeat
State Street Corp Purchases 668,318 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
How to Take Advantage of moves in (CELC) - Stock Traders Daily
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Consensus Target Price from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionCelcuity (NASDAQ:CELC), Apellis Pharmaceuticals (NASDAQ:APLS) - Benzinga
Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Charles Schwab Investment Management Inc. Purchases 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Investment Report - Stock Traders Daily
BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity reports survival data for breast cancer drug - Investing.com
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire
Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com
500: Something went wrong - Investing.com India
Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com
Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey
RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com
COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com
Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada
3.95%
2.39%
자본화:
|
볼륨(24시간):